[PDF][PDF] Pathogenic germline variants in 10,389 adult cancers
We conducted the largest investigation of predisposition variants in cancer to date, discovering
853 pathogenic or likely pathogenic variants in 8% of 10,389 cases from 33 cancer types. …
853 pathogenic or likely pathogenic variants in 8% of 10,389 cases from 33 cancer types. …
Comprehensive genomic characterization of upper tract urothelial carcinoma
Background Upper urinary tract urothelial cancer (UTUC) may have unique etiologic and
genomic factors compared to bladder cancer. Objective To characterize the genomic …
genomic factors compared to bladder cancer. Objective To characterize the genomic …
[PDF][PDF] Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy
We demonstrate that concurrent administration of poly(ADP-ribose) polymerase (PARP)
and WEE1 inhibitors is effective in inhibiting tumor growth but poorly tolerated. Concurrent …
and WEE1 inhibitors is effective in inhibiting tumor growth but poorly tolerated. Concurrent …
Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder
SH Kim, TB Kim, SW Kim, SJ Oh - The Journal of urology, 2009 - Elsevier
PURPOSE: In this study we identify the characteristics of the urodynamic results in patients
with painful bladder syndrome/interstitial cystitis and in those with idiopathic overactive …
with painful bladder syndrome/interstitial cystitis and in those with idiopathic overactive …
Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape
Purpose: Sarcomatoid renal cell carcinoma (SRCC) ranks among the most aggressive
clinicopathologic phenotypes of RCC. However, the paucity of high-quality, genome-wide …
clinicopathologic phenotypes of RCC. However, the paucity of high-quality, genome-wide …
Phase Ib dose expansion and translational analyses of olaparib in combination with capivasertib in recurrent endometrial, triple-negative breast, and ovarian cancer
Purpose: On the basis of strong preclinical rationale, we sought to confirm recommended
phase II dose (RP2D) for olaparib, a PARP inhibitor, combined with the AKT inhibitor …
phase II dose (RP2D) for olaparib, a PARP inhibitor, combined with the AKT inhibitor …
Survival Outcomes by TP53 Mutation Status in Metastatic Breast Cancer
Purpose To determine the significant genomic alterations in patients with metastatic breast
cancer (MBC) and survival outcomes in common genotypes. Patients and Methods High-…
cancer (MBC) and survival outcomes in common genotypes. Patients and Methods High-…
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
Hybrid oncocytic/chromophobe tumor (HOCT) of the kidney represents a poorly understood
clinicopathologic entity with pathologic features that overlap between benign renal …
clinicopathologic entity with pathologic features that overlap between benign renal …
[HTML][HTML] Second to fourth digit ratio: a predictor of adult penile length
…, KH Kim, H Jung, SJ Yoon, SW Kim… - Asian journal of …, 2011 - ncbi.nlm.nih.gov
The second to fourth digit ratio (2D: 4D) has been proposed as a putative biomarker for
prenatal testosterone and covaries with the sensitivity of the androgen receptor (AR). Both …
prenatal testosterone and covaries with the sensitivity of the androgen receptor (AR). Both …
[HTML][HTML] Life-threatening complication after extracorporeal shock wave lithotripsy for a renal stone: a hepatic subcapsular hematoma
TB Kim, HK Park, KY Lee, KH Kim, H Jung… - Korean Journal of …, 2010 - ncbi.nlm.nih.gov
Extracorporeal shock wave lithotripsy (ESWL) has revolutionized the management of
urolithiasis since it was first introduced in 1980. ESWL is a well-established, safe and effective …
urolithiasis since it was first introduced in 1980. ESWL is a well-established, safe and effective …
